BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 45 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $7,000 | – | 13,616 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cypress Point Wealth Management, LLC | 1,887,509 | $7,871,000 | 7.30% |
| Naviter Wealth, LLC | 1,555,636 | $6,487,000 | 1.94% |
| INVERNESS COUNSEL LLC /NY/ | 1,210,537 | $5,048,000 | 0.19% |
| Allegheny Financial Group LTD | 11,595 | $48,000 | 0.02% |
| BALDWIN BROTHERS LLC/MA | 38,604 | $161,000 | 0.02% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 39,635 | $165,000 | 0.00% |
| Jump Financial, LLC | 15,552 | $65,000 | 0.00% |
| Carmichael Hill & Associates, Inc. | 1,500 | $6,000 | 0.00% |
| Renaissance Technologies | 297,709 | $1,241,000 | 0.00% |
| Cubist Systematic Strategies, LLC | 46,489 | $194,000 | 0.00% |